MorphoSys (MOR) Competitors

MorphoSys (NASDAQ:MOR) and Ascendis Pharma A/S (NASDAQ:ASND) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, dividends, analyst recommendations, institutional ownership, community ranking, valuation and profitability.

Does the MarketBeat Community prefer MOR or ASND?

Ascendis Pharma A/S received 431 more outperform votes than MorphoSys when rated by MarketBeat users. Likewise, 67.26% of users gave Ascendis Pharma A/S an outperform vote while only 38.46% of users gave MorphoSys an outperform vote.

Company	Underperform	Outperform
MorphoSys	Outperform Votes 25 38.46%	Underperform Votes 40 61.54%
Ascendis Pharma A/S	Outperform Votes 456 67.26%	Underperform Votes 222 32.74%

Do analysts prefer MOR or ASND?

Ascendis Pharma A/S has a consensus price target of $217.73, indicating a potential upside of 26.80%. Given Ascendis Pharma A/S's stronger consensus rating and higher possible upside, analysts plainly believe Ascendis Pharma A/S is more favorable than MorphoSys.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MorphoSys	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Ascendis Pharma A/S	0 Sell rating(s)	0 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do insiders and institutionals have more ownership in MOR or ASND?

18.4% of MorphoSys shares are owned by institutional investors. 0.1% of MorphoSys shares are owned by insiders. Comparatively, 40.0% of Ascendis Pharma A/S shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Which has more volatility & risk, MOR or ASND?

MorphoSys has a beta of 1.2, meaning that its stock price is 20% more volatile than the S&P 500. Comparatively, Ascendis Pharma A/S has a beta of 0.37, meaning that its stock price is 63% less volatile than the S&P 500.

Is MOR or ASND more profitable?

Ascendis Pharma A/S has a net margin of -104.54% compared to MorphoSys' net margin of -226.79%. Ascendis Pharma A/S's return on equity of 0.00% beat MorphoSys' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MorphoSys	-226.79%	-694.31%	-22.55%
Ascendis Pharma A/S	-104.54%	N/A	-39.23%

Which has stronger valuation & earnings, MOR or ASND?

MorphoSys has higher earnings, but lower revenue than Ascendis Pharma A/S. Ascendis Pharma A/S is trading at a lower price-to-earnings ratio than MorphoSys, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MorphoSys	$238.28M	11.99	-$205.35M	-$3.48	-5.45
Ascendis Pharma A/S	$368.70M	28.45	-$409.12M	-$6.28	-27.34

Does the media favor MOR or ASND?

In the previous week, Ascendis Pharma A/S had 14 more articles in the media than MorphoSys. MarketBeat recorded 14 mentions for Ascendis Pharma A/S and 0 mentions for MorphoSys. Ascendis Pharma A/S's average media sentiment score of 0.96 beat MorphoSys' score of 0.00 indicating that Ascendis Pharma A/S is being referred to more favorably in the news media.

Company	Overall Sentiment
MorphoSys	Neutral
Ascendis Pharma A/S	Positive

Summary

Ascendis Pharma A/S beats MorphoSys on 12 of the 18 factors compared between the two stocks.